Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL

By Dominici S.   Laguardia M.E.   Serafini G.   Chiarantini L.   Fortini C.   Tripiciano A.   Brocca-Cofano E.   Scoglio A.   Caputo A.   Fiorelli V.   Gavioli R.   Cafaro A.   Ensoli B.   Magnani M.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2082-2090

Elsevier

Access to resources Recommend Favorite

Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implications for immunotherapy of recurrent HSV infection

By York L.J.   Giorgio D.P.   Mishkin E.M.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1706-1712

Elsevier

Access to resources Recommend Favorite

A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in nave and infection-primed mice

By Ruitenberg K.M.   Walker C.   Love D.N.   Wellington J.E.   Whalley J.M.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1367-1373

Elsevier

Access to resources Recommend Favorite

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

By Fries L.F.   Tartaglia J.   Taylor J.   Kauffman E.K.   Meignier B.   Paoletti E.   Plotkin S.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 428-434

Elsevier

Access to resources Recommend Favorite

Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems

By Mohamedi S.A.   Brewer J.M.   Alexander J.   Heath A.W.   Jennings R.  

Vaccine, Vol. 18, Iss. 20, 2000-04 ,pp. : 2083-2094

Elsevier

Access to resources Recommend Favorite